Inna Rashkivska , Mykola Produnchuk , Nadiia Nedopytanska , Petro Zhminko , Mojmir Mach , Yana Kolianchuk
{"title":"在威斯达汉诺威大鼠中进行了对农药Асеtаmіprіd的研究","authors":"Inna Rashkivska , Mykola Produnchuk , Nadiia Nedopytanska , Petro Zhminko , Mojmir Mach , Yana Kolianchuk","doi":"10.1016/j.etap.2025.104833","DOIUrl":null,"url":null,"abstract":"<div><div>Available data on pesticide Acetamiprid (ACE) are insufficient to clarify the uncertainties identified neurotoxicity. The current DNT study of ACE was conducted according to the OECD TG 426 and GLP requirements to clarify uncertainties. ACE was administered orally by gavage Wistar Hannover rats at dose levels of 0, 2.5, 10 and 45 mg/kg/bw/day. Maternal toxicity was expressed at a dose level of 45 mg/kg/bw/day. Developmental toxicity was indicated at a dose level of 45 mg/kg/bw/day. Regarding ACE developmental neurotoxicity, administration at 10 and 45 mg/kg body weight/day affected the acoustic startle response and locomotor activity, with no observed structural brain changes. Based on the study findings, the No-Observed-Adverse-Effect Level (NOAEL) for maternal toxicity was determined to be 10 mg/kg bw/day. The NOAEL was identified as 2.5 mg/kg bw/day for developmental neurotoxicity. A developmental neurotoxicity study of ACE demonstrated that neurotoxicity is a critical limiting factor for the compound's overall toxicity.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"119 ","pages":"Article 104833"},"PeriodicalIF":4.2000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dеvеlоpmеntаl nеurоtоxісіty study оf pesticide Асеtаmіprіd in Wistar Hannover rats\",\"authors\":\"Inna Rashkivska , Mykola Produnchuk , Nadiia Nedopytanska , Petro Zhminko , Mojmir Mach , Yana Kolianchuk\",\"doi\":\"10.1016/j.etap.2025.104833\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Available data on pesticide Acetamiprid (ACE) are insufficient to clarify the uncertainties identified neurotoxicity. The current DNT study of ACE was conducted according to the OECD TG 426 and GLP requirements to clarify uncertainties. ACE was administered orally by gavage Wistar Hannover rats at dose levels of 0, 2.5, 10 and 45 mg/kg/bw/day. Maternal toxicity was expressed at a dose level of 45 mg/kg/bw/day. Developmental toxicity was indicated at a dose level of 45 mg/kg/bw/day. Regarding ACE developmental neurotoxicity, administration at 10 and 45 mg/kg body weight/day affected the acoustic startle response and locomotor activity, with no observed structural brain changes. Based on the study findings, the No-Observed-Adverse-Effect Level (NOAEL) for maternal toxicity was determined to be 10 mg/kg bw/day. The NOAEL was identified as 2.5 mg/kg bw/day for developmental neurotoxicity. A developmental neurotoxicity study of ACE demonstrated that neurotoxicity is a critical limiting factor for the compound's overall toxicity.</div></div>\",\"PeriodicalId\":11775,\"journal\":{\"name\":\"Environmental toxicology and pharmacology\",\"volume\":\"119 \",\"pages\":\"Article 104833\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Environmental toxicology and pharmacology\",\"FirstCategoryId\":\"93\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S138266892500208X\",\"RegionNum\":3,\"RegionCategory\":\"环境科学与生态学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENVIRONMENTAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S138266892500208X","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
Dеvеlоpmеntаl nеurоtоxісіty study оf pesticide Асеtаmіprіd in Wistar Hannover rats
Available data on pesticide Acetamiprid (ACE) are insufficient to clarify the uncertainties identified neurotoxicity. The current DNT study of ACE was conducted according to the OECD TG 426 and GLP requirements to clarify uncertainties. ACE was administered orally by gavage Wistar Hannover rats at dose levels of 0, 2.5, 10 and 45 mg/kg/bw/day. Maternal toxicity was expressed at a dose level of 45 mg/kg/bw/day. Developmental toxicity was indicated at a dose level of 45 mg/kg/bw/day. Regarding ACE developmental neurotoxicity, administration at 10 and 45 mg/kg body weight/day affected the acoustic startle response and locomotor activity, with no observed structural brain changes. Based on the study findings, the No-Observed-Adverse-Effect Level (NOAEL) for maternal toxicity was determined to be 10 mg/kg bw/day. The NOAEL was identified as 2.5 mg/kg bw/day for developmental neurotoxicity. A developmental neurotoxicity study of ACE demonstrated that neurotoxicity is a critical limiting factor for the compound's overall toxicity.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.